1 A prospective study on urine alkalization with an oral regimen consisting of sodium bicarbonate and acetazolamide in patients receiving high-dose methotrexate.

2 Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.

3 TEL-AML-1 fusion gene in children with acute lymphoblastic in basra pediatric oncology center

4 the intriguing occurrence of acute myeloid leukemia in a case of acute lymphoblastic leukemia:report of two cases

5 trichosporon fungemia in a pediatric patient with acute lymphoblastic leukemia

6 acute lymphoblastic leukemia with normal platelet count

7 the role of the central nervous system microenvironment in pediatric acute lymphoblastic leukemia

8 evaluation of prognostic and predictive factors in pediatric acute lymphoblatic leukemia patients admitted to shahid sadoughi hospital

9 disseminated cunninghamella bertholletiae infection during induction chemotherapy in a girl with high-risk acute lymphoblastic leukemia

10 unilateral exudative retinal detachment as the sole presentation of relapsing acute lymphoblastic leukemia

11 the role of micro-ribonucleic acids in normal hematopoiesis and leukemic t-lymphogenesis

12 validación del ultramicrométodo inmunocitoquímico (umiciq) para el inmunofenotipaje de la leucemia linfoide aguda pediátrica validation of immunocytochemical ultramicromethod (umiciq) for immunophenotyping of pediatric acute lymphoid leukemia

13 medical image of the week: bronchial clot removal via cryotherapy

14 role of integrin alpha4 in drug resistance of leukemia

15 inotuzumab ozogamicin: a cd22 mab–drug conjugate for adult relapsed or refractory b-cell precursor acute lymphoblastic leukemia

16 Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia

17 Idarubicin and high-dose cytarabine in the treatment of refractory and relapsed acute lymphoblastic leukemia

18 Fatigue trajectories during pediatric ALL therapy are associated with fatigue after treatment: a national longitudinal cohort study.

19 Integrating expert opinion with clinical trial data to extrapolate long-term survival: a case study of CAR-T therapy for children and young adults with relapsed or refractory acute lymphoblastic leukemia.

20 Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.

21 Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

22 Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia: A case report and literature review.

23 Paternal Smoking Before Conception and During Pregnancy Is Associated With an Increased Risk of Childhood Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis of 17 Case-Control Studies.

24 Synergistic action of dual IGF1/R and MEK inhibition sensitizes childhood acute lymphoblastic leukemia (ALL) cells to cytotoxic agents and involves downregulation of STAT6 and PDAP1.

25 Successful Treatment of Fanconi Anemia and T-Cell Acute Lymphoblastic Leukemia

26 Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment

27 High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis

28 Two types of intracytoplasmic inclusions in the cells of a patient with acute lymphoblastic leukemia

29 acute lymphoblastic leukemia presenting solely as low back pain

30 a proven case of cutaneous rhizopus infection presenting with severe limb pain very soon after induction treatment in a patient with acute lymphoblastic leukemia

31 isolated skin relapse of philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic stem cell transplant

32 acute tumor lysis syndrome secondary to a single-dose methylprednisolone in acute lymphoblastic leukemia

33 survival outcomes of a population-based cohort of adolescent and young adult (aya), acute lymphoblastic leukemia (all) patients in ontario, canada: the impact cohort

34 skin nodules in a 16-year-old adolescent with acute lymphoblastic leukemia

35 cutaneous sarcoid reaction in a case of acute lymphoblastic leukemia

36 new challenges in targeting signaling pathways in acute lymphoblastic leukemia by ngs approaches: an update

37 an integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor b-lineage acute lymphoblastic leukemia

38 diagnosis of a t-lineage acute lymphoblastic leukemia through digitalized cell analysis of the pleural effusion

39 shorter maintenance therapy in childhood acute lymphoblastic leukemia. the experience of the prospective, randomized brazilian gbtli all-93 protocol.

40 outcome of adolescents with acute lymphoblastic leukemia treated by pediatrics versus adults protocols

41 successful resolution of epsteinâbarr virus-associated hemophagocytic lymphohistiocytosis during the treatment course of acute lymphoblastic leukemia

42 valosin-containing protein/p97 as a novel therapeutic target in acute lymphoblastic leukemia

43 a possible role for wnt5a hypermethylation in pediatric acute lymphoblastic leukemia

44 dor óssea e sua relação na apresentação inicial da leucemia linfóide aguda bone pain and its relation to the initial presentation of acute lymphoblastic leukemia

45 cytometric evaluation of transferrin receptor 1 (cd71) in childhood acute lymphoblastic leukemia

46 γδ t-cell acute lymphoblastic leukemia/lymphoma: discussion of two pediatric cases and its distinction from other mature γδ t-cell malignancies

47 characterization of acute lymphoblastic leukemia subtypes in moroccan children

48 unusual cytochemical reactivity for toluidine blue in granular acute lymphoblastic leukemia: a report of two rare cases

49 presença de anticorpo anti-lutheran b em paciente com leucemia linfóide aguda anti-lutheran b in a patient with acute lymphoblastic leukemia

50 changing of ikzf1 genotype during philadelphia-negative precursor-b acute lymphoblastic leukemia progression: a short clinical report

51 kidney and pancreatic extramedullary relapse in adult acute lymphoblastic leukemia: a case report and review of the literature

52 B- Acute Lymphoblastic Leukemia L2 In Second Trimester of Pregnancy

53 Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells

54 Synthetic triterpenoids have cytotoxicity in pediatric acute lymphoblastic leukemia cell lines but cytotoxicity is independent of induced ceramide increase in MOLT-4 cells - Leukemia

55 Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study

56 Risk factors of central venous lines-related thrombosis in children with acute lymphoblastic leukemia during induction therapy: a prospective study - Leukemia

57 Children with Standard Risk Acute Lymphoblastic Leukemia in Induction And Consolidation Phase

58 [Clinical Analysis of Dasatinib and Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia].

59 Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.

60 Management of Adult Acute Lymphoblastic Leukemia: A Review.

Keyword Connections

Journals

Research Groups

Bibliographies